Juergen K. Willmann, M.D.
Publication Details
-
Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
Radiology. 2008; (3): 936-44
To develop and validate a dual-targeted ultrasonographic (US) imaging agent with microbubbles (MBs) that attaches to both vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) and alpha(v)beta(3) integrin and to compare the US imaging signal obtained from dual-targeted MBs (MB(D)) with that from single-targeted MBs (MB(S)) in a murine model of tumor angiogenesis.
